By Tony Fong

NEW YORK (GenomeWeb News) – Established diagnostics firms such as Roche and Abbott can have the batch processing market, as far as Biocartis is concerned. The Swiss-based start-up has its eyes on the decentralized molecular diagnostics space.

In February, Biocartis acquired Royal Philips Electronics' molecular diagnostic platform, and is now in the process of building it out in expectations of a late-2012 launch.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.